The startup has developed a proprietary selenium-based antimicrobial compound platform that prevents biofilm formation on surfaces and materials. This technology effectively inhibits the growth of bacteria, fungi, and viruses, enhancing hygiene and safety in various applications.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biofilm formation on surfaces and materials leads to the growth of harmful bacteria, fungi, and viruses, posing significant hygiene and safety challenges across various industries. Healthcare-associated infections, dental plaque, and material degradation are all consequences of unchecked microbial proliferation.
Solution
SelenBio has developed SELDOX, a selenium-based antimicrobial compound platform designed to prevent biofilm formation. SELDOX is non-toxic, non-leaching, and easily polymerized or surface-coated, making it suitable for integration into a wide range of products. The technology inhibits microbial growth with high efficacy, potentially reaching inhibition rates of up to 99.999999%. SelenBio is applying SELDOX in dentistry to combat cavities and plaque, in animal health to protect pets from tartar and periodontal disease, and in healthcare to reduce healthcare-associated infections. SelenBio Chemical, a separate licensed entity, focuses on developing antimicrobial surface treatments and coatings using SELDOX technology.
Target Audience
SelenBio's primary customers include manufacturers of medical devices, dental products, animal health products, and coatings, as well as healthcare providers and dental professionals seeking to improve hygiene and safety.
Features
- Selenium-based antimicrobial compound effective against bacteria, fungi, and viruses
- Prevents biofilm formation on surfaces and materials
- Non-toxic and non-leaching formulation
- Easily polymerized or surface-coated for versatile application
- Demonstrated efficacy in dentistry, animal health, and healthcare settings
- Potential microbial inhibition rates up to 99.999999%